Frank Brown

About

Frank Brown, PhD, has served as Senior Vice President and Chief Science Officer for Accelrys since October 2006. Frank has extensive experience in the areas of computational chemistry and chemoinformatics. He is responsible for both the scientific direction of the company and all collaborative research with academic, government and industrial partners. Prior to joining Accelrys, Frank held positions of increasing responsibility at Johnson & Johnson, most recently as senior research fellow within the Office of the CIO. In this position, Frank oversaw the development of architecture for all R&D in the organization's pharma sector. Before Johnson & Johnson, Frank started the first chemoinformatics group in the industry at Glaxo Research Institute, and launched software products targeted to the pharmaceutical industry as vice president for product and business development at Oxford Molecular Group. Frank has also served as an adjunct associate professor in the Department of Medicinal Chemistry, School of Pharmacy, at the University of North Carolina at Chapel Hill. He has also served as a chair for the American Chemical Society (ACS), Computers in Chemistry section, and on an NIH Special Study. Frank holds a PhD in physical organic chemistry from the University of Pittsburgh and a post-doctoral studies degree in bio physics from the University of California at San Francisco. He can be reached at fbrown@accelrys.com.

How to Mine Scientific Business Intelligence in the Cloud

Before the rise of the mammoth database, before e-mail, electronic laboratory notebooks (ELNs), and global Centers of Excellence, R&D innovation was centered on personal communication at the company lunch table. It was here that project team leaders-such as the head chemist, pharmacologist, biologist and other select stakeholders-would gather to share their knowledge. The rich insights […]

How to Leverage IT to Speed RandD Innovation

Picture this: Your R&D department is under the gun to create a new line of shampoos and conditioners ahead of the competition. Yet, designing the right formulation requires accessing, integrating and analyzing an enormous amount of data-everything from information about the thousands of possible ingredients available to complex molecular simulations that show how various combinations […]